Infliximab treatment of postoperative ulcers in Crohn's disease: to inject or not to inject--that is the question.
Blonski
Wojciech
W
Lichtenstein
Gary R
GR
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D005765:Gastrointestinal Agents / Q000008:administration & dosage*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D000069285:Infliximab; D015552:Injections, Intralesional; D055502:Secondary Prevention; D014456:Ulcer / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D007155:Immunologic Factors; D000069285:Infliximab